Completed PHASE1 INTERVENTIONAL 1-arm NCT03264651

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

A Single-Centre Pilot Trial Investigating the Efficacy and Safety of Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

Sponsor: GTx

Conditions Mammographic Density

Interventions enobosarm

Updated 6 times since 2017 Last updated: Apr 17, 2018 Started: Feb 1, 2017 Primary completion: Mar 21, 2018 Completion: Mar 21, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Mammographic Density and is currently completed. GTx leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
May 2018 — Jun 2018 [monthly]

Completed PHASE1

Status: Recruiting → Completed

▶ Show 1 earlier version

Sep 2017 — May 2018 [monthly]

Recruiting PHASE1

First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GTx
Havah Therapeutics Pty Ltd

Data source: Havah Therapeutics Pty Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toorak Gardens, Australia